EDITFORCE
EditForce develops drugs and seeds by using nucleic acid (DNA/RNA) manipulation technologies.
EDITFORCE
Industry:
Biotechnology Medical Nursing And Residential Care
Founded:
2015-05-15
Address:
Fukuoka, Fukuoka, Japan
Country:
Japan
Website Url:
http://www.editforce.co.jp
Total Employee:
11+
Status:
Active
Contact:
1-092-802-4935
Email Addresses:
[email protected]
Total Funding:
1.85 B JPY
Technology used in webpage:
SPF Domain Not Resolving Mobile Non Scaleable Content Microsoft Exchange Online Office 365 Mail Microsoft Azure DNS Ruby On Rails Token OpenSSL Ruby On Rails Otsuka
Similar Organizations
Enterin
Philadelphia-based biotechnology company .
Pepgen
PepGen is empowering nucleic acid therapeutics to go the distance.
Scholar Rock
Scholar Rock is a biopharmaceutical company that develops and discovers new medicines and treatments for the serious diseases.
Slingshot Biosciences
Slingshot Biosciences develops next-generation synthetic cells for diagnostics and therapeutics.
Spark Therapeutics
Spark Therapeutics is focused on the development of gene therapy.
Current Advisors List
Current Employees Featured
Founder
Investors List
ITOCHU Technology Ventures
ITOCHU Technology Ventures investment in Venture Round - EditForce
Newton Biocapital
Newton Biocapital investment in Venture Round - EditForce
Global Brain Corporation
Global Brain Corporation investment in Venture Round - EditForce
UTEC - The University of Tokyo Edge Capital Partners
UTEC - The University of Tokyo Edge Capital Partners investment in Venture Round - EditForce
ITOCHU Technology Ventures
ITOCHU Technology Ventures investment in Series B - EditForce
K4 Ventures
K4 Ventures investment in Series B - EditForce
Newton Biocapital
Newton Biocapital investment in Series B - EditForce
Japan Science and Technology Agency
Japan Science and Technology Agency investment in Series B - EditForce
UTEC - The University of Tokyo Edge Capital Partners
UTEC - The University of Tokyo Edge Capital Partners investment in Series B - EditForce
QB Capital
QB Capital investment in Series B - EditForce
Official Site Inspections
http://www.editforce.co.jp
- Host name: sv14116.xserver.jp
- IP address: 162.43.120.117
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "EditForce"
EditForce, Inc. - New Tools Lead to a New World
Mar 7, 2025 JP / EN. Innovative gene therapy with Japan's novel RNA-editing technology. New Tools Lead to a New World. See our strength. news. 2025.03.07. Information. EditForce further elucidated the mechanism of RNA …See details»
About - EditForce, Inc.
May 15, 2015 Company Name: EditForce, Inc. Established:May 15, 2015, Capital:JPY 90,000,000,President and CEO:Takashi Ono, Head office:4F Fukuoka Tenjin Fukoku Seimei …See details»
Company - EditForce, Inc.
We have developed an innovative gene control technology based on the mechanism of RNA editing by PPR proteins in plant.See details»
EDITFORCE, INC. Company Profile - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for EDITFORCE, INC. of CHIYODA-KU, TOKYO. Get the latest business insights from Dun & Bradstreet.See details»
EditForce Inc.｜投資先企業｜UTEC-The University of Tokyo Edge …
EditForce Inc. develops novel drugs, seeds (for agriculture), and useful substances through nucleic acids (DNA / RNA) manipulation technologies. UTEC has been involved in EditForce …See details»
エディットフォース株式会社 - UTEC-東京大学エッジ ...
海外で先行するzfn、talen、crispr等のゲノム編集技術に対し、日本発のゲノム編集技術を事業化すべく、九州大学の中村崇裕准教授が発明したppr技術をコア技術として2015年5月に設立See details»
EditForce - Crunchbase Company Profile & Funding
EditForce closed its last funding round on May 26, 2021 from a Venture - Series Unknown round. Who are EditForce 's competitors? Alternatives and possible competitors to EditForce may include Pepgen , Slingshot Biosciences , and …See details»
EditForce Company Profile - Office Locations, Competitors, …
EditForce (エディットフォース株式会社) is a company specializing in DNA/ RNA manipulation technology. It develops pentatricopeptide repeat (PPR) proteins as DNA/RNA editing tools to …See details»
History - EditForce, Inc.
JP / EN. HOME. Company. History. History. 2015. 05. Established EditForce, Inc. 12. ... Undertook New Energy and Industrial Technology Development Organization (NEDO)'s …See details»
エディットフォース株式会社 | InfoBase
エディットフォース株式会社. 会社概要 「pprプラットフォーム技術」という独自のrna編集技術を開発・提供し、その技術を応用した遺伝子治療薬の研究開発を行っています。See details»
EditForce - Overview, News & Similar companies | ZoomInfo.com
Jul 5, 2022 EditForce's headquarters are located at 9f saiwai bldg 1-3-1 Uchisaiwai-cho, Chiyoda-ku, Tokyo, Tokyo, 100-0011, Japan What is EditForce's official website? EditForce's …See details»
EditForce, Inc. | Global Startup Acceleration Program (GSAP) …
EditForce, Inc. JETRO Startup Global Startup Acceleration Program (GSAP) Alumnis EditForce, Inc. CIC '22 Bio/Healthcare Healthcare Biotech Website; We strive to discover and develop …See details»
EditForce 2025 Company Profile: Valuation, Funding & Investors
EditForce General Information Description. Developer of a protein creation technology designed to offer genome editing services. The company's technology provides tetratricopeptide repeat …See details»
世界初のRNA編集技術、医療のリスクを軽減し世の中に貢献（前…
May 26, 2022 2015年5月、老舗化学系商社のkisco（株）と九州大学教授・中村崇裕氏らによって設立された九州大学発ベンチャー・エディットフォース（株）。See details»
私たちの強み - エディットフォース株式会社
私たちは、PPRプラットフォーム技術を応用した遺伝子治療薬の研究開発を行っています。 RNAを標的に多様な遺伝子制御を行うことができ、また幅広くDDS（薬物送達システ …See details»
EditForce - Products, Competitors, Financials, Employees, …
EditForce is a venture company specializing in RNA editing technology for drug development in the biotechnology sector. Use the CB Insights Platform to explore EditForce's full profile. ...See details»
エディットフォース株式会社｜スピーダ スタートアップ情報リ …
May 21, 2023 独自のRNA編集技術を用いて遺伝子治療薬を開発。 細胞内外を問わず、標的ゲノムやRNAを自在に操作・改変することができるRNA編集技術「PPRプラットフォーム技術 …See details»
Newton Biocapital invests in EditForce to support development
Jul 1, 2021 Brussels, Belgium / Tokyo, Japan – 1 July 2021 – Newton Biocapital (“Newton”), a life sciences investment fund active in Europe and Japan and focused on the treatment and …See details»
研究発表 - エディットフォース株式会社
Ichinose, M., Teramoto, T., Nakamura, I. et al. Fine-tuning of the PPR protein directs the RNA editing activity toward C-to-U or U-to-C conversion. Sci Rep 15, 6288 (2025). Ping, N., Hara …See details»
Apple shuffles AI executive ranks in bid to turn around Siri
2 days ago The changes allowed two of Rockwell’s trusted executives to evaluate the organization before he became heavily involved. Inside Apple, Rockwell hasn’t been shy about …See details»